Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
253.40    -0.40 (-0.16%)
Bid:
253.20
Ask:
253.60
Spread: 0.40 (0.158%)
Market Cap: £2.50b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Directorate Change

12 Jan 2021 12:00

RNS Number : 3934L
Serco Group PLC
12 January 2021
 

12 January 2021

Serco Group plc ('Serco' or 'the Company')

LEI: 549300PT2CIHYN5GWJ21

 

Directorate Change - Non-Executive Director Appointment

 

Serco, the international provider of services to governments, announces that Tim Lodge has been appointed as a Non-Executive Director of Serco and a member of the Group Audit, Group Risk and Remuneration Committees with effect from 21 February 2021. He will replace John Rishton as chair of the Audit Committee when John Rishton succeeds Sir Roy Gardner as chair of the Company on 21 April 2021.

 

Tim Lodge was previously Chief Financial Officer at Tate & Lyle PLC and COFCO International. Having recently stepped down as a Non-Executive Director and chair of the Audit Committee of Aryzta AG, he is currently a Non-Executive Director of FTSE 250 SSP Group plc, the leading operator of food and beverage concessions in travel locations, and a Non-Executive Director and chair of the Audit Committee of Arco Limited, the family-owned supplier of safety wear and equipment.

 

Sir Roy Gardner, Non-Executive Chairman of Serco, commented: "I am very pleased to welcome Tim to the Board of Serco. He has a wealth of financial experience and a strong track record in driving commercial performance, as well as delivering strategic change and restructuring to support longer term investment and growth; he will be a very welcome addition to the Board." 

 

Serco confirms that there are no further disclosures required under the Listing Rules in respect of Tim Lodge.

 

 

For further information please contact Serco:

Paul Checketts, Head of Investor Relations T +44 (0) 7718 195074

Marcus De Ville, Head of Media Relations T +44 (0) 7738 898 550

 

About Serco

Serco is a leading provider of public services. Our customers are governments or others operating in the public sector. We gain scale, expertise and diversification by operating internationally across five sectors and four geographies: Defence, Justice & Immigration, Transport, Health and Citizen Services, delivered in UK & Europe, North America, Asia Pacific and the Middle East.

 

More information can be found at www.serco.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFLFSEEFSESF
Date   Source Headline
5th Jun 20265:36 pmRNSTransaction in Own Shares
29th May 20265:35 pmRNSTransaction in Own Shares and Total Voting Rights
26th May 20267:00 amRNSSerco secures £270m contract from NNUH
22nd May 20265:14 pmRNSTransaction in Own Shares
15th May 20265:24 pmRNSTransaction in Own Shares
8th May 20265:25 pmRNSTransaction in Own Shares
30th Apr 20265:37 pmRNSTransactions in own shares and Total Voting Rights
24th Apr 20265:17 pmRNSTransactions in Own Shares
22nd Apr 20264:00 pmRNSResult of AGM
17th Apr 20265:34 pmRNSTransactions in Own Shares
10th Apr 20265:39 pmRNSTransactions in Own Shares
10th Apr 20263:46 pmRNSDirector/PDMR Shareholding
7th Apr 20265:35 pmRNSDirector/PDMR Shareholding
31st Mar 20265:21 pmRNSTransactions in Own Shares and Total Voting Rights
27th Mar 20263:03 pmRNSDirector/PDMR Shareholding
20th Mar 20265:50 pmRNSTransaction in Own Shares
18th Mar 20265:15 pmRNSHolding(s) in Company
18th Mar 202611:00 amRNSPublication of the 2025 ARA and 2026 Notice of AGM
13th Mar 20265:25 pmRNSTransaction in Own Shares
11th Mar 20265:46 pmRNSTransaction in Own Shares and Total Voting Rights
5th Mar 20267:02 amRNSShare Repurchase Programme
5th Mar 20267:00 amRNS2025 full year results
19th Feb 20265:45 pmRNSHolding(s) in Company
9th Feb 20265:30 pmRNSHolding(s) in Company
5th Feb 202612:30 pmRNSHolding(s) in Company
2nd Feb 20265:45 pmRNSTotal Voting Rights and Capital
29th Jan 20265:30 pmRNSHolding(s) in Company
5th Jan 20265:30 pmRNSHolding(s) in Company
31st Dec 20259:00 amRNSTotal Voting Rights and Capital
31st Dec 20259:00 amRNSTotal Voting Rights and Capital
23rd Dec 20254:00 pmRNSHolding(s) in Company
23rd Dec 20254:00 pmRNSHolding(s) in Company
19th Dec 20257:30 amRNSCancellation of Treasury Shares
19th Dec 20257:30 amRNSCancellation of Treasury Shares
17th Dec 20257:01 amRNSCFO Retirement
17th Dec 20257:00 amRNSSerco pre-close trading update
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20254:30 pmRNSBlock listing Interim Review
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSSerco awarded UK prison contract
28th Nov 20256:20 pmRNSTransactions in own shares and Total Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.